Hemodialysis (HD) patients hospitalized for infections receive significantly higher amounts of replacement IV iron therapy and cumulative iron dose, according to findings presented here at the National Kidney Foundation 2010 Spring Clinical Meetings.
ORLANDO, Fla.—Correcting iron deficiency in non-dialysis CKD patients lowers platelet counts and improves erythropoiesis, researchers reported here at the National Kidney Foundation’s 2010 Spring Clinical Meetings.
Elevated levels of serum alkaline phosphatase in hemodialysis (HD) patients may predict coronary artery calcification (CAC), which is associated with cardiovascular and mortality in this population.
NASHVILLE—Researchers who analyzed data from clinical trials of darbepoetin alfa in anemic non-dialysis CKD patients found that all patients experience variable hemoglobin (Hb) levels, although the degree of fluctuation may vary.